Explore the Global Nipah Virus (NiV) Infection Testing Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Nipah Virus (NiV) Infection Testing Market

Key Insight

Nipah virus (NiV) infection testing sales will grow through 2036, led by RT-PCR based kits at 63.4% of the test type in 2026. The market was valued at USD 2.27 billion in 2025 and is expected to be worth USD 3.81 billion by 2036, creating an incremental opportunity of USD 1.51 billion.

May 26, 2026

Anurag Sharma

292 Pages

Cite this Report

Nipah Virus (NiV) Infection Testing Market

https://www.futuremarketinsights.com/reports/nipah-virus-infection-testing-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Bio-Rad Laboratories
Biovac
CDC
Cepheid
Lunit
NIV-Pune
Owlstone Medical
Qiagen
Hoffmann-La Roche
Siemens
Thermo Fisher Scientific Inc.
WHO

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Nipah Virus (NiV) Infection Testing Market

Key Players

Similar Industry Reports